Showing results (11-20 of 46) with videos related to

Sort By:
Pageof 5
Cancer Letters|May 1, 2018
Co-targeting of BET proteins and HDACs as a novel approach to trigger apoptosis in rhabdomyosarcoma cellsJulius C Enßle, Cathinka Boedicker, Marek Wanior, et al.
Cancer Letters|September 27, 2017
BCL-x<sub>L</sub>-selective BH3 mimetic sensitizes rhabdomyosarcoma cells to chemotherapeutics by activation of the mitochondrial pathway of apoptosisSara Fatima Faqar-Uz-Zaman, Ulrike Heinicke, Michael Torsten Meister, et al.
Cancer Research|November 17, 2005
Sensitization for gamma-irradiation-induced apoptosis by second mitochondria-derived activator of caspaseStavros Giagkousiklidis, Meike Vogler, Mike-Andrew Westhoff, et al.
Oncogene|August 11, 2005
Inhibition of clonogenic tumor growth: a novel function of Smac contributing to its antitumor activityMeike Vogler, Stavros Giagkousiklidis, Felicitas Genze, et al.
Biomolecules|July 26, 2020
DLBCL Cells with Acquired Resistance to Venetoclax Are Not Sensitized to BIRD-2 But Can Be Resensitized to Venetoclax through Bcl-XL InhibitionMartijn Kerkhofs, Tamara Vervloessem, Kinga B Stopa, et al.
Blood|November 28, 2008
Small molecule XIAP inhibitors cooperate with TRAIL to induce apoptosis in childhood acute leukemia cells and overcome Bcl-2-mediated resistanceMelanie Fakler, Sandra Loeder, Meike Vogler, et al.
Biochemical and Biophysical Research Communications|April 26, 2011
The B-cell lymphoma 2 (BCL2)-inhibitors, ABT-737 and ABT-263, are substrates for P-glycoproteinMeike Vogler, David Dickens, Martin J S Dyer, et al.
Cell Death and Differentiation|December 14, 2019
Next-generation hypomethylating agent SGI-110 primes acute myeloid leukemia cells to IAP antagonist by activating extrinsic and intrinsic apoptosis pathwaysJessica Dittmann, Tinka Haydn, Patrick Metzger, et al.
Journal of Hematology & Oncology|December 14, 2020
MCL-1 inhibitors, fast-lane development of a new class of anti-cancer agentsArnold Bolomsky, Meike Vogler, Murat Cem Köse, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 6, 2010
Diminished sensitivity of chronic lymphocytic leukemia cells to ABT-737 and ABT-263 due to albumin binding in bloodMeike Vogler, Silviya D Furdas, Manfred Jung, et al.
Pageof 5